<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have generated cytotoxic T-lymphocytes (CTLs) from the peripheral blood (PB) of eight B-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) patients by in vitro coculture with autologous fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Their functional activity was assessed in <z:chebi fb="0" ids="50076">51Cr</z:chebi> release assay and was found to be MHC class I restricted </plain></SENT>
<SENT sid="2" pm="."><plain>Our results indicate the presence of T-cells cytotoxic for autologous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in the PB of these patients but these were relatively small numbers in small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLLs</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment of fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with rIFN-gamma and rTNF-alpha alone, or in combination significantly increased their susceptibility in 4/5 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLLs</z:e>, and a case of diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), while, B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, rich in T-cells, did not show any appreciable increase </plain></SENT>
<SENT sid="4" pm="."><plain>Fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells were also analysed for MHC class I and ICAM-1 antigens by flow cytometry, in 5/8 cases before and after cytokine treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Significant upregulation of MHC class I antigens but with no detectable change in ICAM-1 observed in a case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SLL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, correlated with enhanced susceptibility </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest the possible role of MHC class I antigens in the cytotoxic susceptibility of autologous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in B-cell NHL </plain></SENT>
</text></document>